HIV-1 specific reverse transcriptase inhibitors:: Why are TSAO-nucleosides so unique?

被引:34
作者
Camarasa, MJ
San-Félix, A
Pérez-Pérez, MJ
Velázquez, S
Alvarez, R
Chamorro, C
Jimeno, ML
Pérez, C
Gago, F
De Clercq, E
Balzarini, J
机构
[1] CSIC, Inst Quim Med, E-28006 Madrid, Spain
[2] Univ Alcala de Henares, Dept Farmacol, Madrid, Spain
[3] Katholieke Univ Leuven, Rega Inst Med Res, B-3000 Louvain, Belgium
关键词
D O I
10.1080/07328300008544093
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
[No abstract available]
引用
收藏
页码:451 / 469
页数:19
相关论文
共 75 条
[1]   1,2,3-TRIAZOLE-[2',5'-BIS-O-(TERT-BUTYLDIMETHYLSILYL)-BETA-D-RIBOFURANOSYL]-3'-SPIRO-5''-(4''-AMINO-1'',2''-OXATHIOL 2'',2''-DIOXIDE) (TSAO) ANALOGS - SYNTHESIS AND ANTI-HIV-1 ACTIVITY [J].
ALVAREZ, R ;
VELAZQUEZ, S ;
SANFELIX, A ;
AQUARO, S ;
DECLERCQ, E ;
PERNO, CF ;
KARLSSON, A ;
BALZARINI, J ;
CAMARASA, MJ .
JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (24) :4185-4194
[2]   Novel TSAO derivatives, synthesis and anti-HIV-1 activity of allofuranosyl-TSAO-T analogues [J].
Alvarez, R ;
SanFelix, A ;
DeClercq, E ;
Balzarini, J ;
Camarasa, MJ .
NUCLEOSIDES & NUCLEOTIDES, 1996, 15 (1-3) :349-359
[3]   Synthesis and anti-human immunodeficiency virus type 1 activity of novel 3'-spiro nucleoside analogues of TSAO-T [J].
Alvarez, R ;
Jimeno, ML ;
PerezPerez, MJ ;
DeClercq, E ;
Balzarini, J ;
Camarasa, MJ .
ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, 1997, 8 (06) :507-517
[4]  
Alvarez R, 1998, ANTIVIR CHEM CHEMOTH, V9, P333
[5]   [2',5'-BIS-O-(TERT-BUTYLDIMETHYLSILYL)]-3'-SPIRO-5''-(4''-AMINO-1'',2''-OXATHIOLE-2'',2''-DIOXIDE) (TSAO) DERIVATIVES OF PURINE AND PYRIMIDINE NUCLEOSIDES AS POTENT AND SELECTIVE INHIBITORS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 [J].
BALZARINI, J ;
PEREZPEREZ, MJ ;
SANFELIX, A ;
VELAZQUEZ, S ;
CAMARASA, MJ ;
DECLERCQ, E .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (05) :1073-1080
[6]   2',5'-BIS-O-(TERT-BUTYLDIMETHYLSILYL)-3'-SPIRO-5''-(4''-AMINO-1',2''-OXATHIOLE-2'',2''-DIOXIDE)PYRIMIDINE (TSAO) NUCLEOSIDE ANALOGS - HIGHLY SELECTIVE INHIBITORS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 THAT ARE TARGETED AT THE VIRAL REVERSE-TRANSCRIPTASE [J].
BALZARINI, J ;
PEREZPEREZ, MJ ;
SANFELIX, A ;
SCHOLS, D ;
PERNO, CF ;
VANDAMME, AM ;
CAMARASA, MJ ;
DECLERCQ, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (10) :4392-4396
[7]  
BALZARINI J, 1992, J BIOL CHEM, V267, P11831
[8]  
Balzarini J, 1996, METHOD ENZYMOL, V275, P472
[9]   SENSITIVITY OF (138 GLU-]LYS) MUTATED HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) REVERSE-TRANSCRIPTASE (RT) TO HIV-1-SPECIFIC RT-INHIBITORS [J].
BALZARINI, J ;
KLEIM, JP ;
RIESS, G ;
CAMARASA, MJ ;
DECLERCQ, E ;
KARLSSON, A .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 201 (03) :1305-1312
[10]  
Balzarini Jan, 1993, Drugs of the Future, V18, P1043